Emerson Electric (EMR) is up 3.2% today. Here is some analysis on what might have caused this price movement.
Analysis: The move appears tied to improving sentiment after a recent analyst upgrade that highlighted backlog strength and a stronger second-half setup. Support also likely came from Emerson’s existing 2026 outlook and the approach of its next earnings report, which can draw buyers when expectations are constructive.
Details:
Emerson is scheduled to report third-quarter 2026 results after the market closes on August 4, 2026, putting investor focus back on near-term execution.In its most recent quarterly update, the company said underlying orders rose 5% and described its backlog as robust, with management pointing to a stronger second half of 2026.That same quarterly release kept a full-year adjusted EPS outlook of $6.45 to $6.55 and free cash flow guidance of $3.5 billion to $3.6 billion, reinforcing a stable operating backdrop.A recent Wall Street upgrade cited project backlog strength and expected second-half support from large, long-cycle projects, which could be helping drive today’s gain.Sources:
Emerson, Emerson, Investing.com
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$EMR Insider Trading Activity

$EMR insiders have traded $EMR stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $EMR stock by insiders over the last 6 months:
- RAM R. KRISHNAN (Executive Vice Pres & COO) sold 11,500 shares for an estimated $1,624,030
- NICHOLAS J. PIAZZA (Senior VP & CPO) sold 6,703 shares for an estimated $1,066,244
- SURENDRALAL LANCA KARSANBHAI (President & CEO) sold 5,700 shares for an estimated $811,227
- MARK A BLINN has made 0 purchases and 2 sales selling 2,876 shares for an estimated $438,929.
- MATTHEW S LEVATICH sold 1,476 shares for an estimated $239,348
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Quiver Alerts
Receive EMR Data Alerts
Get market-moving data, filings, and signals for EMR in real time.
Sign Up
$EMR Hedge Fund Activity
We have seen 881 institutional investors add shares of $EMR stock to their portfolio, and 919 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 3,353,823 shares (-25.9%) from their portfolio in Q1 2026, for an estimated $439,417,889
- BANK OF AMERICA CORP /DE/ added 2,302,055 shares (+13.1%) to their portfolio in Q1 2026, for an estimated $301,615,246
- NUVEEN, LLC removed 1,967,305 shares (-34.5%) from their portfolio in Q1 2026, for an estimated $257,756,301
- BOSTON PARTNERS removed 1,832,743 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $240,125,987
- SCHRODER INVESTMENT MANAGEMENT GROUP removed 1,699,587 shares (-22.8%) from their portfolio in Q1 2026, for an estimated $222,679,888
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,346,290 shares (+92.6%) to their portfolio in Q1 2026, for an estimated $176,390,915
- PHOENIX FINANCIAL LTD. added 1,314,656 shares (+19025.4%) to their portfolio in Q1 2026, for an estimated $172,246,229
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$EMR Government Contracts
We have seen $5,455,452 of award payments to $EMR over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
$EMR Congressional Stock Trading
Members of Congress have traded $EMR stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $EMR stock by members of Congress over the last 6 months:
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$EMR Price Targets
Multiple analysts have issued price targets for $EMR recently. We have seen 11 analysts offer price targets for $EMR in the last 6 months, with a median target of $169.0.
Here are some recent targets:
- Chris Dankert from DA Davidson set a target price of $145.0 on 06/16/2026
- Varun Govindaraj from Bernstein set a target price of $175.0 on 06/10/2026
- Joseph O'Dea from Wells Fargo set a target price of $155.0 on 05/07/2026
- Deane Dray from RBC Capital set a target price of $169.0 on 05/06/2026
- Julian Mitchell from Barclays set a target price of $144.0 on 05/06/2026
- Stephen Volkmann from Jefferies set a target price of $175.0 on 03/31/2026
- Daniel DiCicco from BMO Capital set a target price of $150.0 on 03/27/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Read full article here »
Emerson Electric shares rise as recent analyst upgrade and backlog optimism support sentiment
Emerson Electric (EMR) is up 3.2% today. Here is some analysis on what might have caused this price movement.
Analysis: The move appears tied to improving sentiment after a recent analyst upgrade that highlighted backlog strength and a stronger second-half setup. Support also likely came from Emerson’s existing 2026 outlook and the approach of its next earnings report, which can draw buyers when expectations are constructive.
Details:
Sources:
Emerson, Emerson, Investing.com
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$EMR Insider Trading Activity
$EMR insiders have traded $EMR stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $EMR stock by insiders over the last 6 months:
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$EMR Hedge Fund Activity
We have seen 881 institutional investors add shares of $EMR stock to their portfolio, and 919 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$EMR Government Contracts
We have seen $5,455,452 of award payments to $EMR over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
$EMR Congressional Stock Trading
Members of Congress have traded $EMR stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $EMR stock by members of Congress over the last 6 months:
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$EMR Price Targets
Multiple analysts have issued price targets for $EMR recently. We have seen 11 analysts offer price targets for $EMR in the last 6 months, with a median target of $169.0.
Here are some recent targets:
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Read full article here »